In Vitro Microbiological Characterization of Novel Macrolide CP-163, 505 for Animal Health Specific Use
スポンサーリンク
概要
- 論文の詳細を見る
- 1998-02-25
著者
-
Hayashi S
Pfizer Inc Ct
-
Hayashi Shigeru
Pfizer Global Research & Development And Veterinary Medicine Research & Development Pfizer I
-
Hecker S
Microcide Pharmaceuticals Ca
-
NORCIA Laura
Central Research Division, Pfizer Inc.
-
SEIBEL Scott
Central Research Division, Pfizer Inc.
-
KAMICKER Barbara
Central Research Division, Pfizer Inc.
-
LEMAY Mary
Central Research Division, Pfizer Inc.
-
LILLEY Susan
Central Research Division, Pfizer Inc.
-
HECKER Scott
Central Research Division, Pfizer Inc.
-
BERGERON Jay
Central Research Division, Pfizer Inc.
-
RETSEMA James
Central Research Division, Pfizer Inc.
-
HAYASHI Shigeru
Central Research Division, Pfizer Inc.
-
Lilley Susan
Central Research Division Pfizer Inc.
-
Norcia Laura
Pfizer Global Research & Development And Veterinary Medicine Research & Development Pfizer I
-
Bergeron Jay
Central Research Division Pfizer Inc.
-
Retsema James
Central Research Division Pfizer Inc.
-
Lemay Mary
Central Research Division Pfizer Inc.
-
Seibel Scott
Central Research Division Pfizer Inc.
-
Kamicker Barbara
Central Research Division Pfizer Inc.
関連論文
- Discovery of RWJ-54428 (MC-02,479), a New Cephalosporin Active Against Resistant Gram-positive Bacteria
- Discovery of MC-02,331, a New Cephalosporin Exhibiting Potent Activity Against Methicillin-resistant Staphylococcus aureus
- In Vitro Microbiological Characterization of Novel Macrolide CP-163, 505 for Animal Health Specific Use
- In Vitro Microbiological Characterization of Novel Cyclic Homopentapeptides, CP - 101,680 and CP - 163,234, for Animal Health Use
- In Vitro Microbiological Characterization of a Novel Azalide, Two Triamilides and an Azalide Ketal against Bovine and Porcine Respiratory Pathogens
- Structure-activity Relationships of Hygromycin A and Its Analogs: Protein Synthesis Inhibition Activity in a Cell Free System